BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37544512)

  • 1. The clinical impact of early detection of ESBL-producing Enterobacterales with PCR-based blood culture assays.
    Chang KM; Haghamad A; Saunders-Hao P; Shaffer A; Mirsaidi N; Zimilover A; Epstein M; Jain S; Streva V; Juretschko S; Demissie S; Gautam-Goyal P
    Am J Infect Control; 2024 Jan; 52(1):73-80. PubMed ID: 37544512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the clinical impact of rapid multiplex polymerase chain reaction-based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration.
    Britt NS; Khader K; He T; Willson TM; Effiong A; Timbrook TT; Potter EM; Lodise TP
    Pharmacotherapy; 2023 Jan; 43(1):24-34. PubMed ID: 36484553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures.
    Tansarli GS; Chapin KC
    Microbiol Spectr; 2022 Oct; 10(5):e0179622. PubMed ID: 36069598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Integrating Rapid PCR-Based Blood Culture Identification Panel to an Established Antimicrobial Stewardship Program in the United Arab of Emirates.
    Nasef R; El Lababidi R; Alatoom A; Krishnaprasad S; Bonilla F
    Int J Infect Dis; 2020 Feb; 91():124-128. PubMed ID: 31786245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of Adding a Rapid PCR-Based Blood Culture Identification Panel to an Established Antimicrobial Stewardship Program.
    MacVane SH; Nolte FS
    J Clin Microbiol; 2016 Oct; 54(10):2455-63. PubMed ID: 27487951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia.
    MacVane SH; Hurst JM; Boger MS; Gnann JW
    Infect Dis (Lond); 2016 Oct; 48(10):732-7. PubMed ID: 27196015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Broad-Panel PCR-Based Bacterial Identification for Blood Cultures in a Pediatric Oncology Population.
    Garner CD; Brazelton de Cardenas J; Suganda S; Hayden RT
    Microbiol Spectr; 2021 Sep; 9(1):e0022121. PubMed ID: 34232100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex
    Bryant S; Almahmoud I; Pierre I; Bardet J; Touati S; Maubon D; Cornet M; Richarme C; Maurin M; Pavese P; Caspar Y
    Front Cell Infect Microbiol; 2020; 10():594951. PubMed ID: 33324578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a Rapid Blood Culture Diagnostic Panel on Time to Optimal Antimicrobial Therapy at a Veterans Affairs Medical Center.
    Chiasson JM; Smith WJ; Jodlowski TZ; Kouma MA; Cutrell JB
    J Pharm Pract; 2022 Oct; 35(5):722-729. PubMed ID: 33813935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT).
    Claeys KC; Hopkins TL; Schlaffer K; Hitchcock S; Jiang Y; Evans S; Johnson JK; Leekha S
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0044121. PubMed ID: 34228533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of rapid polymerase chain reaction-based organism identification of gram-positive cocci for patients with a single positive blood culture.
    MacVane SH; Raux BR; Smith TT
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1471-1479. PubMed ID: 31079314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.
    McCarty TP; Cumagun P; Meeder J; Moates D; Edwards WS; Hutchinson J; Lee RA; Leal SM
    Microbiol Spectr; 2023 Feb; 11(1):e0409222. PubMed ID: 36688641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children's Hospital.
    Graff KE; Palmer C; Anarestani T; Velasquez D; Hamilton S; Pretty K; Parker S; Dominguez SR
    Microbiol Spectr; 2021 Sep; 9(1):e0042921. PubMed ID: 34431685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of ePlex® blood culture identification panels in clinical isolates and characterization of antimicrobial stewardship opportunities.
    Thomas JK; Clark J; Arora V; Burgess DS; Burgess DR; Mynatt RP; VanHoose JD; Wallace KL; Cotner SE
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116269. PubMed ID: 38692201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray.
    Ny P; Ozaki A; Pallares J; Nieberg P; Wong-Beringer A
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30814265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.
    Wolk DM; Young S; Whitfield NN; Reid JL; Thornberg A; Carroll KC; Buchan BW; Davis TE; Salimnia H
    J Clin Microbiol; 2021 Aug; 59(9):e0248420. PubMed ID: 34232066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections.
    Huang TD; Melnik E; Bogaerts P; Evrard S; Glupczynski Y
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30487304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study.
    Verroken A; Despas N; Rodriguez-Villalobos H; Laterre PF
    PLoS One; 2019; 14(9):e0223122. PubMed ID: 31557233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and performance of the BioFire FilmArray® Blood Culture Identification panel with antimicrobial treatment recommendations for bloodstream infections at a midwestern academic tertiary hospital.
    Southern TR; VanSchooneveld TC; Bannister DL; Brown TL; Crismon AS; Buss SN; Iwen PC; Fey PD
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):96-101. PubMed ID: 25488272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel.
    Carroll KC; Reid JL; Thornberg A; Whitfield NN; Trainor D; Lewis S; Wakefield T; Davis TE; Church KG; Samuel L; Mills R; Jim P; Young S; Nolte FS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31996444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.